A crucial aspect of regenerative healthcare and drug research lies in the ability to multiply human stem cell groups to sufficient numbers for therapeutic applications. Traditionally, constrained cell presence posed a significant barrier to advancement in these fields. Consequently, considerable endeavor has been directed towards improving protocol